EMCURE:NSE
Emcure Pharmaceuticals Ltd
2 330,00 INR
arrow_downward
-0,40%(-9,40) 1D
18-ноя., 15:30:00 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EMCURE...
Open
2 354,90 INR
High
2 402,00 INR
Low
2 326,00 INR
Mkt. cap
443,65 млд
Avg. vol.
231,90 миң
Volume
256,07 миң
Dividend
0,15%
Quarterly dividend
0,90 INR
Ex-dividend date
2026-ж., 4-сен.
P/E ratio
48,91
52-wk high
2 429,90 INR
52-wk low
1 312,30 INR
EPS
47,64 INR
No. of employees
7 миң
Open
2 354,90 INR
High
2 402,00 INR
Low
2 326,00 INR
Mkt. cap
443,65 млд
Avg. vol.
231,90 миң
Volume
256,07 миң
Dividend
0,15%
Quarterly dividend
0,90 INR
Ex-dividend date
2026-ж., 4-сен.
P/E ratio
48,91
52-wk high
2 429,90 INR
52-wk low
1 312,30 INR
EPS
47,64 INR
No. of employees
7 миң
News stories
From web sources and news partners
Barron's
·
46 мүнөт мурун
Generac Jolted After Nvidia Earnings. Why It’s a Top S&P 500 Stock Today.
BigGo Finance
·
2 саат мурун
S&P 500's Shiller P/E Tops 40 Again, Echoing Dot-Com Era Valuations
FOREX.com
·
51 мүнөт мурун
S&P 500 Grasps At Support as Surging Hike Odds, Treasury Yields Threaten Larger Turn
Traders Union
·
1 саат мурун
S&P 500 movement in 1992–2010 often tied to valuation multiples, Brett Caughran notes
Profile
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
About Emcure Pharmaceuticals Ltd
CEOSatish Ramanlal Mehta
Employees6,91 миң
Founded1981-ж., 16-апр.
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteemcure.com